×
Phase 3, Randomized, Open-Label Study Evaluating the Safety and Efficacy of Magrolimab in Combination with Azacitidine in Previously Untreated Patients with TP53-Mutant Acute Myeloid Leukemia
Daver N., Vyas P., Chao M., Xing G., Renard C., Ramsingh G., Sallman DA., Wei AH.
DOI
10.1182/blood-2021-145208
Type
Conference paper
Publication Date
2021-01-01T00:00:00+00:00
Volume
138